From the latest presentation: "
• Trials of next generation titanium body
armour with defence company Lightforce
Australia Pty. Evaluating high volume
repeatability program. Lightforce developing
final product to market." This falls into the Revenue line item, not R&D. That is, AL3 is paid for all printing work, now and if successful, as they are a supplier to the R&D being performed by Lightforce. I am happy with this approach as I see it too speculative and far dated for a company with as limited cash as AL3.
All IMO, please DYOR and GLTAH
AL3 Price at posting:
7.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)